MedPath

A Comparison of LASIK Outcomes Using Two Femtosecond Lasers

Not Applicable
Completed
Conditions
Astigmatism
Myopia
Interventions
Device: Intralase IFS150
Device: Visumax
Registration Number
NCT03063164
Lead Sponsor
Edward E. Manche
Brief Summary

Comparing LASIK outcomes using two femtosecond lasers

Detailed Description

Patients will have a comprehensive eye examination once they express an interest in the study. This includes a slit lamp examination of the front of the eye and a dilated fundoscopic examination of the back of the eye. If there is any pathology noted that would exclude the patient from the study, then the investigator will inform the patient and make an appropriate referral. Patients deemed appropriate for the study after a comprehensive examination including computerized videokeratography can be enrolled. Patients will undergo bilateral simultaneous eye surgery. Which eye is treated with the Intralase IFS 150 and which eye is treated with VisuMax will be randomized so there is a 50% chance for either eye to receive one treatment. Patients will be seen on the day of surgery, post op day one, one month, three months, six months and one year. Patients will receive topical antibiotics in each eye for one week following the procedure. Patients will receive pred forte 1% ophthalmic drops for one week after treatment. Patients will also receive vigamox ophthalmic drops for four days after treatment. All of this is within the usual and customary standard of care for the treatment of patients undergoing LASIK surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Subjects age 21 and older with healthy eyes. Nearsightedness between -0.25 diopters and -11.00 diopters with or without astigmatism of up to 5.00 diopters.
Exclusion Criteria
  • Subjects under the age of 21
  • Subjects over the age of 60
  • Subjects with corneal ectatic disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intralase IFSIntralase IFS150Intralase IFS vs. Visumax
VisumaxVisumaxVisumax vs. Intralase iFS
Primary Outcome Measures
NameTimeMethod
ETDRS Uncorrected Visual AcuityAt post-operative month 12

Number of eyes with an uncorrected visual acuity of 20/20 at 12 months measured using ETDRS testing charts

Secondary Outcome Measures
NameTimeMethod
Patient Reported Outcomes With LASIKOne month, three months, six months and twelve months

PROWL study questionnaire

Best Spectacle Corrected Visual AcuityPostoperative month 12

Number of eyes losing 2 or more lines of corrected distance visual acuity measured by ETDRS testing charts

Cochet Bonnet Asthesiometry Measurement of Corneal SensationAt postoperative month twelve

Cochet Bonnet Asthesiometry is measured on a scale of 1-6. Scores of 5 and above are considered normal.

AberrometryOne three, six and twelve months

Aberrometry images will be obtained on the iDesign aberrometer

Anterior Segment Ocular Coherence Tomography Measurement of Flap ThicknessAt postoperative month one

Anterior segment ocular coherence tomography

Questionnaire Measuring Patient Preference for Laser DeviceIntraoperative (Approximately 1 minute after completion of surgery)

Participants were asked if they preferred having LASIK surgery with either the Visumax laser, the Intralase iFS laser or had no preference between the two lasers.

Trial Locations

Locations (1)

Byers Eye Institute at Stanford

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath